Inventor · disambiguated record
E-Chiang Lee
Also filed as: LEE E-CHIANG
48 granted patents·64 pending applications·662 citations·filing 2003–2024
98Inventor score
Files withKYMAB LTD98BRADLEY ALLAN4LEE E-CHIANG3LEXICON PHARMACEUTICALS INC2US GOV HEALTH & HUMAN SERV2
Top patents by PatentIndex Score
112 records- 0198US9447177B2Transgenic mouse homozygous for chimeric IgH locusBRADLEY ALLAN·Filed 2012·Granted Sep 20, 2016·36 cites·6 claims
- 0298US9434782B2Animal models and therapeutic moleculesKYMAB LTD·Filed 2013·Granted Sep 6, 2016·31 cites·8 claims
- 0397US10226033B2Animal models and therapeutic moleculesKYMAB LTD·Filed 2017·Granted Mar 12, 2019·13 cites·22 claims
- 0497US10165763B2Animal models and therapeutic moleculesKYMAB LTD·Filed 2013·Granted Jan 1, 2019·13 cites·16 claims
- 0597US9938357B2Animal models and therapeutic moleculesKYMAB LTD·Filed 2016·Granted Apr 10, 2018·21 cites·23 claims
- 0697US9938358B2Animal models and therapeutic moleculesKYMAB LTD·Filed 2016·Granted Apr 10, 2018·19 cites·23 claims
- 0797US9924705B2Animal models and therapeutic moleculesKYMAB LTD·Filed 2016·Granted Mar 27, 2018·20 cites·36 claims
- 0897US9896516B2Animal models and therapeutic moleculesKYMAB LTD·Filed 2016·Granted Feb 20, 2018·20 cites·11 claims
- 0997US9505827B2Animal models and therapeutic moleculesKYMAB LTD·Filed 2013·Granted Nov 29, 2016·27 cites·10 claims
- 1097US9445581B2Animal models and therapeutic moleculesBRADLEY ALLAN·Filed 2012·Granted Sep 20, 2016·51 cites·27 claims
- 1196US10774155B2Animal models and therapeutic moleculesKYMAB LTD·Filed 2018·Granted Sep 15, 2020·9 cites·26 claims
- 1296US10064398B2Animal models and therapeutic moleculesKYMAB LTD·Filed 2014·Granted Sep 4, 2018·14 cites·25 claims
- 1396US9957323B2Anti-ICOS antibodiesKYMAB LTD·Filed 2017·Granted May 1, 2018·27 cites·26 claims
- 1496US9788534B2Animal models and therapeutic moleculesKYMAB LTD·Filed 2013·Granted Oct 17, 2017·18 cites·19 claims
- 1596US9253965B2Animal models and therapeutic moleculesBRADLEY ALLAN·Filed 2012·Granted Feb 9, 2016·35 cites·23 claims
- 1695US10730930B2Antibodies, variable domains and chains tailored for human useKYMAB LTD·Filed 2017·Granted Aug 4, 2020·9 cites·15 claims
- 1795US10149462B2Animal models and therapeutic moleculesKYMAB LTD·Filed 2016·Granted Dec 11, 2018·15 cites·24 claims
- 1895US9504236B2Animal models and therapeutic moleculesKymab Limited; The Bennet Building (B930)·Filed 2015·Granted Nov 29, 2016·29 cites·15 claims
- 1995US7935796B2Monoclonal antibodies against ANGPTL3LEXICON PHARMACEUTICALS INC·Filed 2007·Granted May 3, 2011·74 cites·19 claims
- 2094US11399522B2Animal models and therapeutic moleculesKYMAB LTD·Filed 2021·Granted Aug 2, 2022·2 cites·13 claims
- 2194US10966412B2Animal models and therapeutic moleculesKYMAB LTD·Filed 2018·Granted Apr 6, 2021·11 cites·21 claims
- 2294US9783593B2Antibodies, variable domains and chains tailored for human useKYMAB LTD·Filed 2013·Granted Oct 10, 2017·19 cites·18 claims
- 2393US9783618B2Manipulation of immunoglobulin gene diversity and multi-antibody therapeuticsKYMAB LTD·Filed 2014·Granted Oct 10, 2017·17 cites·12 claims
- 2492US11976135B2FIXaxFX bispecific antibody with common light chainKYMAB LTD·Filed 2020·Granted May 7, 2024·3 cites·19 claims
- 2592US9963716B2Chimaeric surrogate light chains (SLC) comprising human VpreBKYMAB LTD·Filed 2014·Granted May 8, 2018·12 cites·38 claims
- 2691US10667501B2Transgenic non-human vertebrate for the in vivo production of dual specificity immunoglobulins or hypermutated heavy chain only immunoglobulinsKYMAB LTD·Filed 2014·Granted Jun 2, 2020·15 cites·6 claims
- 2789US10815308B2FIXaxFX bispecific antibody with common light chainKYMAB LTD·Filed 2019·Granted Oct 27, 2020·6 cites·17 claims
- 2889US8742075B2Monoclonal antibodies against ANGPTL3LEE E-CHIANG·Filed 2011·Granted Jun 3, 2014·19 cites·17 claims
- 2989US2023263143A1Animal Models and Therapeutic MoleculesKYMAB LTD·Filed 2023·Application pending·0 cites
- 3089US2023225302A1Animal Models and Therapeutic MoleculesKYMAB LTD·Filed 2023·Application pending·0 cites
- 3188US11051497B2Manipulation of immunoglobulin gene diversity and multi-antibody therapeuticsKYMAB LTD·Filed 2014·Granted Jul 6, 2021·5 cites·12 claims
- 3288US7144734B2Enhanced homologous recombination mediated by lambda recombination proteinsUS HEALTH·Filed 2003·Granted Dec 5, 2006·45 cites·36 claims
- 3388US2024200054A1Methods, cells & organismsKYMAB LTD·Filed 2023·Application pending·0 cites
- 3487US7655762B2Monoclonal antibodies against ANGPTL4LEXICON PHARMACEUTICALS INC·Filed 2006·Granted Feb 2, 2010·8 cites·4 claims
- 3587US2023270088A1Animal Models and Therapeutic MoleculesKYMAB LTD·Filed 2022·Application pending·0 cites
- 3687US2024057572A1Animal Models and Therapeutic MoleculesKYMAB LTD·Filed 2022·Application pending·0 cites
- 3786US10337000B2Expression vector production and high-throughput cell screeningKYMAB LTD·Filed 2014·Granted Jul 2, 2019·4 cites·16 claims
- 3885US11858996B2Anti-ICOS antibodiesKYMAB LTD·Filed 2017·Granted Jan 2, 2024·2 cites·29 claims
- 3984US11606941B2Animal models and therapeutic moleculesKYMAB LTD·Filed 2016·Granted Mar 21, 2023·1 cites·20 claims
- 4083US8092796B2Monoclonal antibodies against ANGPTL4LEE E-CHIANG·Filed 2009·Granted Jan 10, 2012·5 cites·18 claims
- 4183US2024343810A1Multispecific antibodies for immuno-oncologyKYMAB LTD·Filed 2024·Application pending·0 cites
- 4281US11564380B2Animal models and therapeutic moleculesKYMAB LTD·Filed 2015·Granted Jan 31, 2023·1 cites·34 claims
- 4381US2024158502A1Anti-icos antibodiesKYMAB LTD·Filed 2023·Application pending·0 cites
- 4480US11297810B2Animal models and therapeutic moleculesKYMAB LTD·Filed 2019·Granted Apr 12, 2022·1 cites·31 claims
- 4580US2023159660A1Animal models and therapeutic moleculesKYMAB LTD·Filed 2022·Application pending·0 cites
- 4678US8591891B2Monoclonal antibodies against ANGPTL4LEE E-CHIANG·Filed 2011·Granted Nov 26, 2013·3 cites·14 claims
- 4778US2020352145A1Animal Models and Therapeutic MoleculesKYMAB LTD·Filed 2020·Application pending·0 cites
- 4878US2020337280A1Animal Models and Therapeutic MoleculesKYMAB LTD·Filed 2020·Application pending·0 cites
- 4978US2023157264A1Animal models and therapeutic moleculesKYMAB LTD·Filed 2022·Application pending·0 cites
- 5077US2020375158A1Animal Models and Therapeutic MoleculesKYMAB LTD·Filed 2020·Application pending·0 cites
Showing the top 50 of 112 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when E-Chiang Lee files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →